Semantic Scholar Open Access 2024 6 sitasi

Therapeutic Potential of Clusterin Inhibition in Human Cancer

D. Martín-García M. García-Aranda Maximino Redondo

Abstrak

Clusterin (CLU) protein is involved in various pathophysiological processes including carcinogenesis and tumor progression. In recent years, the role of the secretory isoform has been demonstrated in tumor cells, where it inhibits apoptosis and favors the acquisition of resistance to conventional treatments used to treat cancer. To determine the possible therapeutic potential of inhibiting this protein, numerous studies have been carried out in this field. In this article, we present the existing knowledge to date on the inhibition of this protein in different types of cancer and analyze the importance it could have in the development of new therapies targeted against this disease.

Topik & Kata Kunci

Penulis (3)

D

D. Martín-García

M

M. García-Aranda

M

Maximino Redondo

Format Sitasi

Martín-García, D., García-Aranda, M., Redondo, M. (2024). Therapeutic Potential of Clusterin Inhibition in Human Cancer. https://doi.org/10.3390/cells13080665

Akses Cepat

Lihat di Sumber doi.org/10.3390/cells13080665
Informasi Jurnal
Tahun Terbit
2024
Bahasa
en
Total Sitasi
Sumber Database
Semantic Scholar
DOI
10.3390/cells13080665
Akses
Open Access ✓